Busey Wealth Management Abb Vie Inc. Transaction History

Busey Wealth Management

$3 Billion
Q3 2024

A detailed history of Busey Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Busey Wealth Management holds 82,500 shares of ABBV stock, worth $14.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

82,500

Previous 82,590 0.11%

Holding current value

$14.3 Million

Previous $14.2 Million 15.02%

% of portfolio

0.54%

Previous 0.49%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$163.84 - $199.33 $14,745 - $17,939	-90 Reduced 0.11%	82,500 $16.3 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $220,730 - $257,763	-1,426 Reduced 1.7%	82,590 $14.2 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $336,740 - $383,684	-2,107 Reduced 2.45%	84,016 $15.3 Million
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $2.37 Million - $2.67 Million	17,234 Added 25.02%	86,123 $13.3 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $681,709 - $789,178	-5,103 Reduced 6.9%	68,889 $10.3 Million
Q2 2023 Jul 21, 2023	SELL	$132.51 - $164.9 $102,695 - $127,797	-775 Reduced 1.04%	73,992 $9.97 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $271,143 - $312,262	-1,875 Reduced 2.45%	74,767 $11.9 Million
Q4 2022 Jan 23, 2023	SELL	$138.31 - $165.87 $190,452 - $228,402	-1,377 Reduced 1.76%	76,642 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $104,281 - $119,603	-777 Reduced 0.99%	78,019 $10.5 Million
Q2 2022 Aug 01, 2022	SELL	$137.62 - $174.96 $452,632 - $575,443	-3,289 Reduced 4.01%	78,796 $12.1 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $310,680 - $385,467	-2,354 Reduced 2.79%	82,085 $13.3 Million
Q4 2021 Jan 25, 2022	SELL	$107.43 - $135.93 $249,345 - $315,493	-2,321 Reduced 2.68%	84,439 $11.4 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $4.03 Million - $4.57 Million	37,869 Added 77.46%	86,760 $9.36 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $155,816 - $173,588	1,481 Added 3.12%	48,891 $5.51 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $60,970 - $67,121	596 Added 1.27%	47,410 $5.13 Million
Q4 2020 Jan 20, 2021	SELL	$80.49 - $108.67 $63,104 - $85,197	-784 Reduced 1.65%	46,814 $5.02 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $58,075 - $68,161	-676 Reduced 1.4%	47,598 $4.17 Million
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $617,188 - $825,890	-8,412 Reduced 14.84%	48,274 $4.74 Million
Q1 2020 Apr 17, 2020	SELL	$64.5 - $97.79 $3,805 - $5,769	-59 Reduced 0.1%	56,686 $4.32 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $8,439 - $10,559	117 Added 0.21%	56,745 $5.03 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.25 Million - $1.51 Million	19,910 Added 54.22%	56,628 $4.29 Million
Q2 2019 Jul 24, 2019	SELL	$65.7 - $83.98 $60,838 - $77,765	-926 Reduced 2.46%	36,718 $2.67 Million
Q1 2019 Apr 16, 2019	BUY	$77.14 - $90.79 $11,802 - $13,890	153 Added 0.41%	37,644 $3.03 Million
Q4 2018 Feb 06, 2019	SELL	$77.85 - $96.01 $25,301 - $31,203	-325 Reduced 0.86%	37,491 $3.46 Million
Q3 2018 Oct 12, 2018	BUY	$88.91 - $98.84 $84,197 - $93,601	947 Added 2.57%	37,816 $3.58 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $57,818 - $68,412	644 Added 1.78%	36,869 $3.42 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $12,973 - $17,372	141 Added 0.39%	36,225 $3.43 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $719,883 - $789,411	8,038 Added 28.66%	36,084 $3.49 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $1.96 Million - $2.5 Million	28,046	28,046 $2.49 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Busey Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Busey Wealth Management with notifications on news.

Account

Busey Wealth Management Abb Vie Inc. Transaction History